One study of smokers found a 55% lower risk of lung cancer among those who consumed SFN.
In animal studies, SFN has been shown to slow the proliferation of lung cancer cells.
Additional human studies investigating the effectiveness of SFN against lung cancer are now underway.


Tang L, Zirpoli GR, Jayaprakash V, Reid ME, McCann SE, Nwogu CE, Zhang Y, Ambrosone CB, Moysich KB. Cruciferous vegetable intake is inversely associated with lung cancer risk among smokers: a case-control study. BMC Cancer. 2010 Apr 27;10:162. doi: 10.1186/1471-2407-10-162. PMID: 20423504; PMCID: PMC2874783.

Wang DX, Zou YJ, Zhuang XB, Chen SX, Lin Y, Li WL, Lin JJ, Lin ZQ. Sulforaphane suppresses EMT and metastasis in human lung cancer through miR-616-5p-mediated GSK3β/β-catenin signaling pathways. Acta Pharmacol Sin. 2017 Feb;38(2):241-251. doi: 10.1038/aps.2016.122. Epub 2016 Nov 28. PMID: 27890917; PMCID: PMC5309754.

Zheng Z, Lin K, Hu Y, Zhou Y, Ding X, Wang Y, Wu W. Sulforaphane metabolites inhibit migration and invasion via microtubule-mediated Claudins dysfunction or inhibition of autolysosome formation in human non-small cell lung cancer cells. Cell Death Dis. 2019 Mar 15;10(4):259. doi: 10.1038/s41419-019-1489-1. PMID: 30874545; PMCID: PMC6420664.

Jiang LL, Zhou SJ, Zhang XM, Chen HQ, Liu W. Sulforaphane suppresses in vitro and in vivo lung tumorigenesis through downregulation of HDAC activity. Biomed Pharmacother. 2016 Mar;78:74-80. doi: 10.1016/j.biopha.2015.11.007. Epub 2016 Jan 14. PMID: 26898427.